I-SPY 2.2 study finds early breast cancer patients may benefit from pre-surgery combination of antibody drug conjugate Dato-DXd and checkpoint inhibitor durvalumab
India launches its first-ever cancer genomics repository, aiming to collect genetic data and improve treatment options tailored specifically for Indian patients